Product Details
Semaglutide
Overview: Semaglutide is a GLP-1 analog with therapeutic applications in type 2 diabetes and obesity. It enhances insulin secretion and reduces appetite, leading to improved glycemic control and weight loss.
Product Specification:
- Purity: >99% (HPLC verified)
- Formulation: Lyophilized powder for reconstitution
- Molecular Formula: C187H291N45O59
- Molecular Weight: 41144 g/mol
- CAS Number: 910463-68-2
- PubChem CID: 56843331
Source: PubChem
Product Features:
- GLP-1 analog simulating human incretin activity
- Enhances insulin secretion and beta cell function
- Delays gastric emptying, reducing appetite
- Supports weight management in obesity
- Exhibits cardioprotective and neuroprotective potential
Research Applications:
- Diabetes Management: Manages blood sugar levels and pancreatic function.
- Obesity Treatment: Aids in significant weight loss through appetite suppression.
- Cardiovascular Health: May improve heart function and reduce heart failure risks.
- Neurological Impact: Potential to protect against neurodegenerative diseases.
Conclusion: Sema is a promising agent in metabolic research, particularly for diabetes and obesity treatments. It offers a multifaceted approach to disease management, impacting several health domains.
Important Notice: This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.
COA Batch 9104-0124-5 (5mg)
Batch 9104-0124-5
COA Batch 9104-0124-10 (10mg)
Batch 9104-0124-10
